These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 26454504

  • 21. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F, Karimpour-Razkenari E, Sameem B, Saeedi M, Firuzi O, Edraki N, Mahdavi M, Akbarzadeh T.
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [Abstract] [Full Text] [Related]

  • 22. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
    Huang L, Shi A, He F, Li X.
    Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
    [Abstract] [Full Text] [Related]

  • 23. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
    Vafadarnejad F, Mahdavi M, Karimpour-Razkenari E, Edraki N, Sameem B, Khanavi M, Saeedi M, Akbarzadeh T.
    Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
    [Abstract] [Full Text] [Related]

  • 24. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors.
    Liu HR, Liu XJ, Fan HQ, Tang JJ, Gao XH, Liu WK.
    Bioorg Med Chem; 2014 Nov 01; 22(21):6124-33. PubMed ID: 25260958
    [Abstract] [Full Text] [Related]

  • 25. Imino-2H-Chromene Based Derivatives as Potential Anti-Alzheimer's Agents: Design, Synthesis, Biological Evaluation and in Silico Study.
    Attarroshan M, Firuzi O, Iraji A, Sharifi S, Tavakkoli M, Vesal M, Khoshneviszadeh M, Pirhadi S, Edraki N.
    Chem Biodivers; 2022 Jan 01; 19(1):e202100599. PubMed ID: 34786830
    [Abstract] [Full Text] [Related]

  • 26. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O, Viayna E, Vicente-García E, Bartolini M, Ramón R, Juárez-Jiménez J, Clos MV, Pérez B, Andrisano V, Luque FJ, Lavilla R, Muñoz-Torrero D.
    Eur J Med Chem; 2014 Feb 12; 73():141-52. PubMed ID: 24389509
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S, Janovec L, Hrabinova M, Spilovska K, Korabecny J, Kristian P, Kuca K, Imrich J.
    J Med Chem; 2014 Aug 28; 57(16):7073-84. PubMed ID: 25089370
    [Abstract] [Full Text] [Related]

  • 28. Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.
    Shen Q, Peng Q, Shao J, Liu X, Huang Z, Pu X, Ma L, Li YM, Chan AS, Gu L.
    Eur J Med Chem; 2005 Dec 28; 40(12):1307-15. PubMed ID: 16182411
    [Abstract] [Full Text] [Related]

  • 29. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB, Palaka BK, Penumala M, Kotapati KV, Devineni SR, Eadlapalli S, Darla MM, Ampasala DR, Vadde R, Amooru GD.
    Eur J Med Chem; 2016 Jan 01; 107():219-32. PubMed ID: 26588065
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and biological evaluation of berberine-thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and Aβ aggregation and antioxidant activity.
    Su T, Xie S, Wei H, Yan J, Huang L, Li X.
    Bioorg Med Chem; 2013 Sep 15; 21(18):5830-40. PubMed ID: 23932451
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X, Fu H, Yang S, Wang L, Liu AL, Wu S, Du GH.
    Molecules; 2017 Jul 26; 22(8):. PubMed ID: 28933746
    [Abstract] [Full Text] [Related]

  • 32. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I, Juárez-Jiménez J, de Los Ríos C, Chioua M, Pouplana R, Luque FJ, Unzeta M, Marco-Contelles J, Samadi A.
    J Med Chem; 2011 Dec 22; 54(24):8251-70. PubMed ID: 22023459
    [Abstract] [Full Text] [Related]

  • 33. Chromone derivatives bearing pyridinium moiety as multi-target-directed ligands against Alzheimer's disease.
    Abdpour S, Jalili-Baleh L, Nadri H, Forootanfar H, Bukhari SNA, Ramazani A, Ebrahimi SES, Foroumadi A, Khoobi M.
    Bioorg Chem; 2021 May 22; 110():104750. PubMed ID: 33691251
    [Abstract] [Full Text] [Related]

  • 34. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
    Lan JS, Ding Y, Liu Y, Kang P, Hou JW, Zhang XY, Xie SS, Zhang T.
    Eur J Med Chem; 2017 Oct 20; 139():48-59. PubMed ID: 28797883
    [Abstract] [Full Text] [Related]

  • 35. Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.
    Kapková P, Stiefl N, Sürig U, Engels B, Baumann K, Holzgrabe U.
    Arch Pharm (Weinheim); 2003 Nov 20; 336(11):523-40. PubMed ID: 14639745
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and acetylcholinesterase and butyrylcholinesterase inhibitory activities of 7-alkoxyl substituted indolizinoquinoline-5,12-dione derivatives.
    Wu ZP, Wu XW, Shen T, Li YP, Cheng X, Gu LQ, Huang ZS, An LK.
    Arch Pharm (Weinheim); 2012 Mar 20; 345(3):175-84. PubMed ID: 21989769
    [Abstract] [Full Text] [Related]

  • 37. Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.
    Altıntop MD, Gurkan-Alp AS, Ozkay Y, Kaplancıklı ZA.
    Arch Pharm (Weinheim); 2013 Aug 20; 346(8):571-6. PubMed ID: 23881696
    [Abstract] [Full Text] [Related]

  • 38. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation.
    Luo W, Li YP, He Y, Huang SL, Tan JH, Ou TM, Li D, Gu LQ, Huang ZS.
    Bioorg Med Chem; 2011 Jan 15; 19(2):763-70. PubMed ID: 21211982
    [Abstract] [Full Text] [Related]

  • 39. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ, Zhu KK, Zhang J, Song JL, Muehlmann LA, Jiang CS, Liu CL, Zhang H.
    Bioorg Chem; 2019 Mar 15; 83():277-288. PubMed ID: 30391700
    [Abstract] [Full Text] [Related]

  • 40. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L, Tan JH, Hou JQ, Huang SL, Gu LQ, Huang ZS.
    Bioorg Med Chem Lett; 2008 Jul 01; 18(13):3790-3. PubMed ID: 18524585
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.